epiregulin (LY3848575)
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 14, 2025
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
(clinicaltrials.gov)
- P2 | N=450 | Active, not recruiting | Sponsor: Eli Lilly and Company | Recruiting ➔ Active, not recruiting
Enrollment closed • Neuralgia • Pain
October 22, 2024
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
(clinicaltrials.gov)
- P2 | N=450 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Neuralgia • Pain
August 23, 2024
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
(clinicaltrials.gov)
- P2 | N=450 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P2 trial • Neuralgia • Pain
1 to 3
Of
3
Go to page
1